SEC Form 4 · accession 0001698998-19-000002
ICU MEDICAL INC/DE · ICUI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel Woolson
Officer — VP, GM-Infusion Capital
Period of report
Feb 13, 2019
Accepted (ET)
Feb 22, 2019 · 12:27 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000883984
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 13, 2019 | M | 2,282 | $0.00 | A | 2,282 | D | |
| Common Stock | Feb 13, 2019 | F | 688 | $0.00 | D | 1,594 | D | |
| Common Stock | Feb 15, 2019 | M | 805 | $0.00 | A | 2,399 | D | |
| Common Stock | Feb 15, 2019 | F | 236 | $0.00 | D | 2,163 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | $0.00 | Feb 13, 2019 | M | 2,282 | D | — | Feb 13, 2020 | Common Stock | 2,282 | 2,282 | D |
| Performance SharesF4,F5,F6 | $0.00 | Feb 15, 2019 | M | 805 | D | — | Feb 15, 2021 | Common Stock | 805 | 1,609 | D |
Explanation of responses
- F1These securities are Restricted Stock Units.
- F2There is neither a purchase price nor an exercise price for the Restricted Stock Units.
- F3One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.
- F4These Securities are Performance Stock Units.
- F5There is neither a purchase price nor an exercise price for the performance stock units.
- F6These performance stock units were granted on March 6, 2018. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These performance stock units vest on February 15 of the first, second, and third year following the year of grant.